Eurofins Scientific SE (OTCMKTS:ERFSF – Get Rating) was the target of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 453,600 shares, a growth of 5.9% from the March 31st total of 428,300 shares. Based on an average daily volume of 1,500 shares, the days-to-cover ratio is currently 302.4 days.
Eurofins Scientific Price Performance
Shares of Eurofins Scientific stock opened at $69.98 on Thursday. The company’s fifty day simple moving average is $67.06 and its two-hundred day simple moving average is $68.32. Eurofins Scientific has a 12-month low of $54.75 and a 12-month high of $93.20.
Wall Street Analysts Forecast Growth
ERFSF has been the subject of a number of analyst reports. Jefferies Financial Group cut shares of Eurofins Scientific from a “hold” rating to an “underperform” rating in a report on Wednesday, January 11th. Sanford C. Bernstein initiated coverage on shares of Eurofins Scientific in a report on Wednesday, April 19th. They set an “underperform” rating on the stock. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Eurofins Scientific from a “hold” rating to a “sell” rating in a research report on Wednesday, January 11th. Three equities research analysts have rated the stock with a sell rating and two have assigned a hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Reduce” and an average price target of $67.50.
Eurofins Scientific Company Profile
Eurofins Scientific SE engages in the bio-analytical testing of food, environment, and pharmaceuticals products. The firm offers testing and laboratory services for agro science, genomics, discovery pharmacology and for supporting clinical studies. It operates through the following geographical segments: Europe, North America, and Rest of the World.
Recommended Stories
- Get a free copy of the StockNews.com research report on Eurofins Scientific (ERFSF)
- Starbucks Stock Becomes a Value Play
- Kraft Heinz Recovery Gains Momentum
- Here’s Why AMD’s Weak Guidance Is A Blessing In Disguise
- BP Shares Sold Off After Earnings: Here Is What Upset Markets
- Will Forced Divesture Of Grail Boost Illumina Shareholder Value?
Receive News & Ratings for Eurofins Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
-logo.jpg&h=45&w=95&zc=2){kind=logo}